Invited Speakers: Alexandre JM, Paris, France
Begaud B, France
Bergman U, Huddinge, Sweden
Bickel U, Marburg, Germany
Böger RH, Hannover, Germany
Breimer D, Leiden, Netherlands
Brockmöller J, Berlin, Germany
Brodie MJ, Glasgow, UK
Brøsen K, Odense, Denmark
Bruppacher R, Basel, Switzerland
Cleland JGF, Glasgow, UK
Cohen AF, Leiden, Netherlands
Dayan AD, London, UK
De Clercq E, Leuven, Belgium
Dobbs SM, London, UK
Dollery C, London, UK
Fuhr U, Cologne, Germany
Ganser A, Hannover, Germany
Ganten D, Berlin, Germany
Garattini S, Milano, Italy
Geisslinger G, Erlangen, Germany
Gram L, Odense, Denmark
Haaijer-Ruskamp F, Groningen, Netherlands
Hallas J, Odense, Denmark
Ingelman-Sundberg M, Stockholm, Sweden
Isakson PC, St. Louis, USA
Jerling M, Gotenburg, Sweden
Kasper S, Vienna, Austria
Kaufman JM, Gent, Belgium
Kivistö KT, Helsinki, Finland
Kroemer H, Stuttgart, Germany
Langman MJS, Birmingham, UK
Lehr CM, Saarbrücken, Germany
Lønning PE, Bergen, Norway
Maurel P. Montpellier, France
Montanaro N, Bologna, Italy
Pairet M, Toulouse, France
Paul M, Berlin, Germany
Pfeilschifter, Basel, Switzerland
Pirmohamed M, Liverpool, UK
Pons G, Paris, France
Poole-Wilson PA, London, UK
Rane A, Uppsala, Sweden
Riethmüller G, Munich, Germany
Rowland M, Manchester, UK
Seyberth HW, Marburg, Germany
Sjöqvist F, Stockholm, Sweden
Smith E, Huddinge, Sweden
Stichtenoth DO, Hannover, Germany
Thürmann P, Frankfurt, Germany
Vallance P, London, UK
Vrhovac B, Zagreb, Croatia
Wehling M, Mannheim, Germany
Wensing G, Wuppertal, Germany
Wolkenstein P, Creteil, France
Woodhouse K, Penarth, UK
Yarranton G, Berkshire, UK
Program:
Plenary lectures
1.Scientific lecture at the opening ceremony
What can clinical pharmacology contribute to patient care?
2.Plenary lecture l
Molecular medicine and clinical pharmacology
3.Plenary lecture ll
The role of clinical pharmacology as viewed by EMEA
4.Plenary lecture lII
Successes and failures in AIDS-therapy
Symposia
1.Teaching in Clinical Pharmacology
2.Drug utilization in Europe
3.Prophylaxis and drug treatment of heart failure: Clinical and economic factors
4.The role of nitric oxide (NO) in drug action in man
5.The impact of molecular biology on clinical pharmacology
6.The challenge for drug therapy of the aging population
7.Adverse drug reactions
8.Strategies in drug treatment of malignant diseases
9.Clinical implications of COX-2 inhibitors
10.What should the clinical pharmacologist know to start a clinical trial (phase l and ll)
11.Ethics in clinical drug research
12.Collaboration of pharmacists and clinical pharmacologists in rational drug use
13.How important are drug interactions?
14.Innovative forms of drug delivery and drug targeting
15.Concentration-guided drug therapy
16.Clinical consequences of extrahepatic drug metabolism
17.Controversies and opportunities in the treatment of CNS disorders
18.The ethical dilemma in the treatment with costly new drugs
19.Perinatal and pediatric clinical pharmacology
Registration :
FGU BERLIN
Fortbildungszentrum Gesundheits- und
Umweltschutz Berlin e.V.
Eisenacher Straße 11
D-10777 Berlin
Germany
Phone: +49-30-21 29 5-3
Fax:+49-30-21 29 5-420
Deadline for Abstracts: 05/10/97
Email for Requests and Registration: kerb@rz.charite.hu-berlin.de